Afatinib use in recurrent epithelial ovarian carcinoma

Amanda L. Shepherd-Littlejohn, Wyatt J. Hanft, Vanessa A Kennedy, Edwin A. Alvarez

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)70-72
Number of pages3
JournalGynecologic Oncology Reports
Volume29
DOIs
StatePublished - Aug 1 2019

Fingerprint

Ovarian Neoplasms
Carcinoma
BIBW 2992

Keywords

  • Afatinib
  • ERBB2
  • HER2/neu
  • Molecular tumor testing
  • Ovarian cancer
  • Targeting agents

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Afatinib use in recurrent epithelial ovarian carcinoma. / Shepherd-Littlejohn, Amanda L.; Hanft, Wyatt J.; Kennedy, Vanessa A; Alvarez, Edwin A.

In: Gynecologic Oncology Reports, Vol. 29, 01.08.2019, p. 70-72.

Research output: Contribution to journalArticle

Shepherd-Littlejohn, Amanda L. ; Hanft, Wyatt J. ; Kennedy, Vanessa A ; Alvarez, Edwin A. / Afatinib use in recurrent epithelial ovarian carcinoma. In: Gynecologic Oncology Reports. 2019 ; Vol. 29. pp. 70-72.
@article{6856eb04904a4c2eb8124e4295c762d6,
title = "Afatinib use in recurrent epithelial ovarian carcinoma",
keywords = "Afatinib, ERBB2, HER2/neu, Molecular tumor testing, Ovarian cancer, Targeting agents",
author = "Shepherd-Littlejohn, {Amanda L.} and Hanft, {Wyatt J.} and Kennedy, {Vanessa A} and Alvarez, {Edwin A.}",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.gore.2019.07.001",
language = "English (US)",
volume = "29",
pages = "70--72",
journal = "Gynecologic Oncology Reports",
issn = "2211-338X",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Afatinib use in recurrent epithelial ovarian carcinoma

AU - Shepherd-Littlejohn, Amanda L.

AU - Hanft, Wyatt J.

AU - Kennedy, Vanessa A

AU - Alvarez, Edwin A.

PY - 2019/8/1

Y1 - 2019/8/1

KW - Afatinib

KW - ERBB2

KW - HER2/neu

KW - Molecular tumor testing

KW - Ovarian cancer

KW - Targeting agents

UR - http://www.scopus.com/inward/record.url?scp=85068895517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068895517&partnerID=8YFLogxK

U2 - 10.1016/j.gore.2019.07.001

DO - 10.1016/j.gore.2019.07.001

M3 - Article

VL - 29

SP - 70

EP - 72

JO - Gynecologic Oncology Reports

JF - Gynecologic Oncology Reports

SN - 2211-338X

ER -